Ardelyx Inc logo

Ardelyx Inc

$ 1.39 +0.02 (+1.46%) 11:31 AM EST
P/E:
At Loss
P/B:
4.04
Market Cap:
$ 214.94M
Enterprise V:
$ 176.49M
Volume:
592.79K
Avg Vol (2M):
3.88M
Also Trade In:
Volume:
592.79K
Market Cap $:
214.94M
PE Ratio:
At Loss
Avg Vol (2-Month):
3.88M
Enterprise Value $:
176.49M
PB Ratio:
4.04
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of molecule and polymeric therapeutics to treat the gastrointestinal tract and cardiorenal diseases. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.
Name Current Vs Industry Vs History
Cash-To-Debt 2.14
Equity-to-Asset 0.4
Debt-to-Equity 0.72
Debt-to-EBITDA -0.29
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -9.24
Distress
Grey
Safe
Beneish M-Score -1.5
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 76.65
9-Day RSI 67.12
14-Day RSI 64.19
6-1 Month Momentum % -6.84
12-1 Month Momentum % -20.44

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.34
Quick Ratio 2.25
Cash Ratio 1.66
Days Inventory 6560.18
Days Sales Outstanding 189.77
Days Payable 6694.72

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -27.7

Financials (Next Earnings Date:2022-11-11 Est.)

ARDX's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ARDX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 5.196
EPS (TTM) ($) -1.13
Beta 0.92
Volatility % 78.12
14-Day RSI 64.19
14-Day ATR ($) 0.097778
20-Day SMA ($) 1.266
12-1 Month Momentum % -20.44
52-Week Range ($) 0.4902 - 1.92
Shares Outstanding (Mil) 154.64

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Ardelyx Inc Filings

Document Form Filing Date
No Filing Data

Ardelyx Inc Analysis

Share your research

Headlines

See More
No news.